BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 12441023)

  • 1. Current update of hormonal and psychotropic drug treatment of premenstrual dysphoric disorder.
    Freeman EW
    Curr Psychiatry Rep; 2002 Dec; 4(6):435-40. PubMed ID: 12441023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management strategies for premenstrual syndrome/premenstrual dysphoric disorder.
    Jarvis CI; Lynch AM; Morin AK
    Ann Pharmacother; 2008 Jul; 42(7):967-78. PubMed ID: 18559957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of premenstrual dysphoric disorder.
    Rapkin AJ; Lewis EI
    Womens Health (Lond); 2013 Nov; 9(6):537-56. PubMed ID: 24161307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Premenstrual syndrome: A mini review.
    Ryu A; Kim TH
    Maturitas; 2015 Dec; 82(4):436-40. PubMed ID: 26351143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What's Stopping Us? Using GnRH Analogs With Stable Hormone Addback in Treatment-Resistant Premenstrual Dysphoric Disorder: Practical Guidelines and Risk-Benefit Analysis for Long-term Therapy.
    Wagner-Schuman M; Kania A; Barone JC; Ross JM; Mulvihill A; Eisenlohr-Moul TA
    J Clin Psychiatry; 2023 Jun; 84(4):. PubMed ID: 37341478
    [No Abstract]   [Full Text] [Related]  

  • 6. [Premenstrual syndrome and premenstrual dysphoric disorder-Overview on pathophysiology, diagnostics and treatment].
    Haußmann J; Goeckenjan M; Haußmann R; Wimberger P
    Nervenarzt; 2024 Mar; 95(3):268-274. PubMed ID: 38393358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A scoping review of hormonal clinical trials in menstrual cycle-related brain disorders: Studies in premenstrual mood disorder, menstrual migraine, and catamenial epilepsy.
    Barone JC; Butler MP; Ross A; Patterson A; Wagner-Schuman M; Eisenlohr-Moul TA
    Front Neuroendocrinol; 2023 Oct; 71():101098. PubMed ID: 37619655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Premenstrual syndrome and premenstrual dysphoric disorder in adolescents.
    Itriyeva K
    Curr Probl Pediatr Adolesc Health Care; 2022 May; 52(5):101187. PubMed ID: 35534402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and treatment of premenstrual dysphoric disorder: an update.
    Steiner M; Born L
    Int Clin Psychopharmacol; 2000 Nov; 15 Suppl 3():S5-17. PubMed ID: 11195269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of treatment of premenstrual syndrome and premenstrual dysphoric disorder.
    Rapkin A
    Psychoneuroendocrinology; 2003 Aug; 28 Suppl 3():39-53. PubMed ID: 12892989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premenstrual dysphoric disorder and severe premenstrual syndrome in adolescents.
    Rapkin AJ; Mikacich JA
    Paediatr Drugs; 2013 Jun; 15(3):191-202. PubMed ID: 23529867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premenstrual syndrome and premenstrual dysphoric disorder: guidelines for management.
    Steiner M
    J Psychiatry Neurosci; 2000 Nov; 25(5):459-68. PubMed ID: 11109297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Pharmacological Approaches to the Management of Premenstrual Dysphoric Disorder.
    Sundström-Poromaa I; Comasco E
    CNS Drugs; 2023 May; 37(5):371-379. PubMed ID: 37171547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An animal model of premenstrual dysphoric disorder sensitive to antidepressants.
    Schneider T; Popik P
    Curr Protoc Neurosci; 2009 Jan; Chapter 9():Unit 9.31. PubMed ID: 19170024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Premenstrual Syndrome: Evidence-based Evaluation and Treatment.
    Appleton SM
    Clin Obstet Gynecol; 2018 Mar; 61(1):52-61. PubMed ID: 29298169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of fluoxetine in the treatment of premenstrual dysphoric disorder.
    Romano S; Judge R; Dillon J; Shuler C; Sundell K
    Clin Ther; 1999 Apr; 21(4):615-33; discussion 613. PubMed ID: 10363729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a unique oral contraceptive (Yasmin) in the management of premenstrual dysphoric disorder.
    Freeman EW
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 3():27-34; discussion 42-3. PubMed ID: 12659404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal management of premenstrual syndrome.
    Usman SB; Indusekhar R; O'Brien S
    Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):251-60. PubMed ID: 17761457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Premenstrual dysphoric disorder. A guide for the treating clinician.
    Elliott H
    N C Med J; 2002; 63(2):72-5. PubMed ID: 12063908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luteal phase administration of agents for the treatment of premenstrual dysphoric disorder.
    Freeman EW
    CNS Drugs; 2004; 18(7):453-68. PubMed ID: 15139800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.